Cumulative Analysis of Early On Pfizer Vaccine Data - released by the FDA 11-17
Pfizer FDA Document Postmarketing Review Review of the first batch of documents released by the FDA including the full scope of reported adverse events from Pfizer. Data collected was from the first…
12 March 2023 | Dr. Mobeen Syed
Pfizer FDA Document Postmarketing Review Review of the first batch of documents released by the FDA including the full scope of reported adverse events from Pfizer. Data collected was from the first 2.5 months of the public roll-out. The document was submitted to the FDA March 2021. Direct link to the FDA released document can be found in the report above.
Full Document Released by the FDA can be found here: 5.3.6-postmarketing-experience